{
  "id": 20932722,
  "title": "Custom MRI tool could show within weeks if pancreatic cancer treatment is working",
  "url": "https://urgent.news/2026/11/20/custom-mri-tool-could-show-within-weeks-if-pancreatic-cancer",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-20T18:40:22.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-11-custom-mri-tool-weeks-pancreatic.html"
  },
  "original_language": "en",
  "account": "Pancreatic cancer often progresses too far for surgery, so chemotherapy is typically the first line of treatment. However, current imaging tools cannot quickly determine if chemotherapy is effective. A new clinical trial at Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute is testing a custom imaging tool called dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). This tool measures blood flow in tumors, providing early indications of treatment success. Led by medical oncologist Shafia Rahman, M.D., the trial will enroll 50 patients with pancreatic ductal adenocarcinoma that can be surgically removed. About 60% of pancreatic cancer patients do not qualify for surgery due to advanced disease. Rahman explains that time is crucial, as even a couple of weeks can significantly impact outcomes. The trial will compare patients treated with standard chemotherapy to those with DCE-MRI, aiming to improve complete surgical resection rates. The DCE-MRI tool, developed by radiology scientist Harrison Kim, Ph.D., offers precise, standardized measurements, potentially improving treatment outcomes by enabling timely adjustments.",
  "summary": "About 60% of people diagnosed with pancreatic cancer don't qualify for surgery because their disease is too advanced. For these patients, treatment typically begins with chemotherapy, in the hope that the tumor will shrink enough to be surgically removed, which offers the best chance of long-term survival. A new clinical trial at The Ohio State University Comprehensive Cancer Center—Arthur G.…",
  "key_points": [
    "DCE-MRI tool measures blood flow in pancreatic tumors for early treatment success indication.",
    "DCE-MRI aims to improve surgical resection rates by enabling timely treatment adjustments."
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}